Open AccessSystematic Review
Machine Learning Models for Predicting Mortality in Hemodialysis Patients: A Systematic Review
by
Alexandru Catalin Motofelea, Adelina Mihaescu, Nicu Olariu, Luciana Marc, Lazar Chisavu, Gheorghe Nicusor Pop, Andreea Crintea, Ana Maria Cristina Jura, Viviana Mihaela Ivan, Adrian Apostol and Adalbert Schiller
Viewed by 81
Abstract
Background: Hemodialysis (HD) patients have significantly higher mortality rates compared to the general population, primarily due to complex comorbidities. This systematic review and meta-analysis aimed to evaluate and compare the performance of various machine learning (ML) models in predicting mortality among HD patients.
[...] Read more.
Background: Hemodialysis (HD) patients have significantly higher mortality rates compared to the general population, primarily due to complex comorbidities. This systematic review and meta-analysis aimed to evaluate and compare the performance of various machine learning (ML) models in predicting mortality among HD patients.
Methods: The analysis followed PRISMA guidelines, including studies that assessed the predictive capabilities of ML models for mortality in HD patients. Review Manager software version 5.4.1. was used for meta-analysis, and the performance of ML models was compared, including logistic regression, XGBoost, and Random Forest models.
Results: The meta-analysis indicated that the logistic regression model predicted a true positive mortality rate of 8.23%, close to the actual rate of 10.53%. In contrast, the XGBoost and Random Forest models predicted rates of 9.93% and 8.94%, respectively, compared to the actual mortality rate of 13.73%. The highest area under the curve (AUC) was reported for the Random Forest model at a 3-year follow-up (AUC = 0.89). No significant difference was found between the performance of logistic regression and Random Forest models (
p = 0.82).
Conclusions: ML models, particularly Random Forest and logistic regression, demonstrated effective predictive capabilities for mortality in HD patients. These models can help identify high-risk patients early, facilitating personalized treatment strategies and potentially improving long-term outcomes. However, the observed heterogeneity among studies indicates a need for further research to refine model performance and standardize predictive features.
Full article
►▼
Show Figures